CREDIT SUISSE AG/ - ARATANA THERAPEUTICS INC ownership

ARATANA THERAPEUTICS INC's ticker is PETX and the CUSIP is 03874P101. A total of 104 filers reported holding ARATANA THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
CREDIT SUISSE AG/ ownership history of ARATANA THERAPEUTICS INC
ValueSharesWeighting
Q2 2019$3,724,000
+5542.4%
721,699
+3787.2%
0.00%
Q1 2019$66,000
-95.5%
18,566
-92.3%
0.00%
-100.0%
Q4 2018$1,473,000
+2275.8%
240,202
+1553.5%
0.00%
Q2 2018$62,000
-55.7%
14,527
-54.5%
0.00%
Q1 2018$140,000
+53.8%
31,905
+84.6%
0.00%
Q4 2017$91,000
-47.4%
17,284
-38.9%
0.00%
Q3 2017$173,000
+76.5%
28,279
+109.0%
0.00%
Q2 2017$98,000
+55.6%
13,528
+12.4%
0.00%
Q1 2017$63,000
-65.4%
12,033
-52.5%
0.00%
Q4 2016$182,000
-71.4%
25,310
-62.8%
0.00%
-100.0%
Q3 2016$636,000
+276.3%
67,999
+154.2%
0.00%
Q2 2016$169,000
+13.4%
26,755
-1.1%
0.00%
Q1 2016$149,000
-23.6%
27,060
-22.2%
0.00%
Q4 2015$195,000
+46.6%
34,770
+120.0%
0.00%
Q3 2015$133,000
-88.4%
15,808
-79.1%
0.00%
-100.0%
Q2 2015$1,144,000
-0.7%
75,677
+5.2%
0.00%0.0%
Q1 2015$1,152,000
+16.7%
71,930
+30.0%
0.00%0.0%
Q4 2014$987,000
+290.1%
55,351
+120.2%
0.00%
Q3 2014$253,000
-41.6%
25,141
-9.4%
0.00%
Q2 2014$433,000
-78.8%
27,746
-74.8%
0.00%
-100.0%
Q1 2014$2,040,000109,9400.00%
Other shareholders
ARATANA THERAPEUTICS INC shareholders Q4 2017
NameSharesValueWeighting ↓
March Altus Capital Management LP 218,515$2,045,00012.79%
Broadfin Capital, LLC 3,085,979$28,885,0002.59%
First Light Asset Management, LLC 467,743$4,378,0001.88%
AWM Investment Company, Inc. 1,005,000$9,407,0001.72%
MPM ASSET MANAGEMENT LLC 250,000$2,340,0000.77%
Grandeur Peak Global Advisors, LLC 394,450$3,692,0000.72%
TURNER INVESTMENTS LLC 208,660$1,953,0000.65%
WALL STREET ASSOCIATES 197,400$1,848,0000.63%
TFS CAPITAL LLC 192,848$1,805,0000.43%
GENERAL AMERICAN INVESTORS CO INC 412,101$3,857,0000.39%
View complete list of ARATANA THERAPEUTICS INC shareholders